Breakthrough cancer researchers at George Mason University launch new company.
George Mason University proteomics researchers Lance Liotta, MD, PhD, and Emanuel Petricoin, PhD, announced the formation of a new company—Theranostics Health, LLC—that will use their breakthrough technology to provide critical new services to medical professionals onthe front line of the war on cancer.